Friday, May 16, 2008
Life Science Network:
Chemie.DE
Bionity.COM
ChemieKarriere.NET
BioKarriere.NET
Companies & Products
Buyer's Guide
Product Gallery
Catalogues
Software
Biotech Books
Antibodies
Market Overview
News Center
Current News
Newsletter
Articles
Special Topics
analytica 2008
RSS-Feeds
Business Club
Information Retrieval
Life Science Encyclopedia
Biotech Search Engine
Job & Career
Events
Toolbox
Specialised Dictionaries
Translation Service
Unit Conversion
Molecular Mass Calculator
Newsletter Subscription
Your e-mail:
Go
About Bionity.COM
The Company
Products & Solutions
Advertising opportunities
Press
Jobs and Careers
Advertising rates
References
Contact
Imprint
Data protection policy
Current News
RSS
Search for:
in:
All
Antibodies
Articles
Catalogues
Companies
Events
Life Science Encyclopedia
Market overviews
News
Product presentations
Software
Search
Target:
Full text
Titel
Company name
Division:
All
Business
Career
Cooperation
Finances
Laws
Manufacturing
Market
People
Politics
Price Development
Products
Research
Technology
Country:
All
Germany
Austria
Switzerland
U.S.A.
United Kingdom
France
Argentina
Australia
Belgium
Brazil
Canada
China
Cuba
Czech Republic
Denmark
Egypt
Estonia
Ethiopia
Finland
France
Greece
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Ireland
Israel
Italy
Japan
Jordan
Kenya
Lebanon
Lithuania
Luxembourg
Malaysia
Mexico
Moldova
Netherlands
New Zealand
Niue
Norway
Peru
Philippines
Poland
Portugal
Puerto Rico
Russia
Rwanda
Singapore
Slovakia
South Africa
South Korea
Spain
Sweden
Taiwan
Thailand
Uganda
Ukraine
United Arab Emirates
Viet Nam
Zambia
From:
To:
Operation:
OR
AND
Search for:
partial
exact
Overview
Companies
Countries
Top News
Tag Clouds
People
Politics
Products
Research
Technology
All
Business
Career
Cooperation
Finances
Laws
Manufacturing
Market
Article
1 to 2
out of
2
for
"IOP"
Ordered by
relevance
alphabet
date
NicOx announces U.S. phase 2a results for PF-03187207 and gives an update on continuing NO-prostaglandin program
(07 May 2008)
a clinically significant reduction in diurnal intraocular pressure (
IOP
) from baseline and the highest dose showed consistently more
IOP
lowering than Xalatan...
more information
QLT initiates phase II study of punctal plug drug delivery system for glaucoma & ocular hypertension
(01 Apr 2008)
for intraocular pressure (
IOP
). Our goal in 2008 is to deliver drug in a punctal plug..., with the aim of leading to a therapeutic drop in
IOP
," said Bob Butchofsky, President...
more information
Additional information matching your search term
Additional information was found matching your search for
"IOP"
.
Life Science Encyclopedia (11)
more
My
Bionity.COM
User:
Password:
Top
© 2001-2008 Chemie.DE Information Service GmbH
a Life Science Network Division
www.Chemie.DE
www.Bionity.COM
www.ChemEurope.COM
www.ChemieKarriere.NET
www.BioKarriere.NET
Top